A novel rhodium-catalyzed cycloisomerization has been developed which converts various acyclic enynes to their cyclic diene isomers with endoselectivity. Both [RhCl(COD)]2/P(4-FC6H4)3 and RhCl(PPh3)3 catalyst systems are effective in promoting the C-C bond-forming cyclization of enynes to furnish carbo- and heterocycles in good to excellent yield. Deuterium labeling studies suggest that the reaction proceeds through the formation of a rhodium vinylidene followed by subsequent [2 + 2] cycloaddition with the alkene and ring-opening of the resulting rhodacyclobutane. These mechanistic studies reevaluate a previously proposed reaction pathway and lead to the discovery of a new cycloisomerization reaction that involves migration of silyl and selenyl substituents at the alkyne of enyne substrates upon cyclization.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2005) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: